Enveric Biosciences Inc (STU:SLZ) Stock News, Headlines & Updates
Enveric Biosciences Inc Stock News from GuruFocus
- 1
Jul 23, 2025
Enveric Biosciences (ENVB) Expands Intellectual Property for Mental Health Treatments | ENVB Stock News
GuruFocus News • 8:16am
Enveric Biosciences Secures Second U.S. Patent Allowance for Next-Generation, Non-Hallucinogenic Mescaline Derivatives in EVM401 Series
Business Wire • 8:00am
Enveric Biosciences Secures Second U.S. Patent Allowance for Next-Generation, Non-Hallucinogenic Mescaline Derivatives in EVM401 Series | ENVB Stock News
GuruFocus News • 7:36am
Jul 15, 2025
Enveric Biosciences (ENVB) Sees Promising Preclinical Results for PTSD Therapy | ENVB Stock News
GuruFocus News • 9:15am
Enveric Biosciences Lead Drug Candidate EB-003 Demonstrates Positive Effects in Preclinical Model of Post-Traumatic Stress Disorder (PTSD)
Business Wire • 9:00am
Enveric Biosciences Lead Drug Candidate EB-003 Demonstrates Positive Effects in Preclinical Model of Post-Traumatic Stress Disorder (PTSD) | ENVB Stock News
GuruFocus News • 8:17am
Jun 24, 2025
Enveric Biosciences Announces Data that Broadens Scope of Clinical Indication Potential for Lead Candidate EB-003
Business Wire • 9:00am
Enveric Biosciences (ENVB) Expands Data on Promising CNS Drug EB-003 | ENVB Stock News
GuruFocus News • 8:45am
Enveric Biosciences Announces Data that Broadens Scope of Clinical Indication Potential for Lead Candidate EB-003 | ENVB Stock News
GuruFocus News • 8:17am
Jun 16, 2025
Enveric Biosciences Announces Participation in 2025 BIO International Convention | ENVB Stock News
GuruFocus News • 10:00am
Enveric Biosciences Announces Participation in 2025 BIO International Convention
Business Wire • 10:00am
Jun 10, 2025
Enveric Biosciences Receives Notice of Allowance for New Class of Low-Hallucinogenic Neuroplastogens Targeting Psychiatric Disorders
Business Wire • 9:00am
Enveric Biosciences (ENVB) Gains Patent Approval for Innovative Compounds | ENVB Stock News
GuruFocus News • 8:31am
Enveric Biosciences Receives Notice of Allowance for New Class of Low-Hallucinogenic Neuroplastogens Targeting Psychiatric Disorders | ENVB Stock News
GuruFocus News • 8:16am
Jun 03, 2025
Enveric Biosciences Announces Issuance of U.S. Patent Covering a Novel Family of Molecules Including Melatonin Receptor-Targeting Compounds
Business Wire • 9:00am
Enveric Biosciences (ENVB) Secures Patent for Novel CNS Therapeutic Compounds | ENVB Stock News
GuruFocus News • 8:46am
Enveric Biosciences Announces Issuance of U.S. Patent Covering a Novel Family of Molecules Including Melatonin Receptor-Targeting Compounds | ENVB Stock News
GuruFocus News • 8:21am
May 28, 2025
Enveric Biosciences Reports Positive Preclinical Results for Lead Drug Candidate EB-003
Business Wire • 9:00am
Enveric Biosciences (ENVB) Reports Promising Preclinical Results for EB-003 | ENVB Stock News
GuruFocus News • 8:31am
Enveric Biosciences Reports Positive Preclinical Results for Lead Drug Candidate EB-003 | ENVB Stock News
GuruFocus News • 8:16am
May 20, 2025
Enveric Biosciences Identifies Neuroplastogen Candidates with Potential to Address Neurodegenerative Disease
Business Wire • 8:00am
Enveric Biosciences (ENVB) Explores New Path with Neurodegenerative Drug Patent | ENVB Stock News
GuruFocus News • 7:33am
Enveric Biosciences Identifies Neuroplastogen Candidates with Potential to Address Neurodegenerative Disease | ENVB Stock News
GuruFocus News • 7:21am
May 14, 2025
Enveric Biosciences Reports First Quarter 2025 Financial and Corporate Results
Business Wire • 4:00pm
Enveric Biosciences Reports First Quarter 2025 Financial and Corporate Results | ENVB Stock News
GuruFocus News • 3:34pm
- 1
Show
Entries
Headlines
Total 0- 1
No recent news